+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CRISPR Market by Offering [Product (Kits, Enzymes, Libraries), Service (gRNA Synthesis, Cell Line Development, Screening, Validation)], Application (Drug Discovery, Development, Agriculture) Competitive Landscape, Company Profiles -Global Forecast to 2030- Product Image
CRISPR Market by Offering [Product (Kits, Enzymes, Libraries), Service (gRNA Synthesis, Cell Line Development, Screening, Validation)], Application (Drug Discovery, Development, Agriculture) Competitive Landscape, Company Profiles -Global Forecast to 2030- Product Image
New

CRISPR Market by Offering [Product (Kits, Enzymes, Libraries), Service (gRNA Synthesis, Cell Line Development, Screening, Validation)], Application (Drug Discovery, Development, Agriculture) Competitive Landscape, Company Profiles -Global Forecast to 2030

  • PDF Icon

    Report

  • 267 Pages
  • May 2025
  • Region: Global
  • Markets and Markets
  • ID: 4699460
Description Jump to:

Rising Focus on CRISPR Therapeutics Development to Drive Market Growth

The global CRISPR market is anticipated to reach USD 5.47 billion by 2030 from USD 3.21 billion in 2025, at a significant CAGR of 11.2%.

The CRISPR market is experiencing substantial growth, with a notable CAGR driven by its increasing adoption in research, clinical, and industrial applications. Several factors contribute to this market expansion, including the rising prevalence of genetic disorders, the growing use of CRISPR in drug discovery and gene therapy, and increased investments in biotechnology research and development. Additionally, advancements in CRISPR tools, improved delivery systems, and supportive regulatory developments further accelerate its integration into mainstream research and therapeutic pipelines.

Products dominated the CRISPR market, by offering, in 2024.

Based on offerings, the CRISPR market is categorized into two main segments: products and services. The products segment includes CRISPR kits & enzymes, CRISPR libraries, and other products. The services segment encompasses gRNA synthesis & cell line development, screening & validation, and other services.

Users are increasingly seeking ongoing innovations, new product releases, and access to standardized, ready-to-use kits. These products are widely utilized in academic, clinical, and industrial research for applications in genome editing, functional genomics, and therapeutic development. This is a key factor driving market growth.

The drug discovery & development application segment is anticipated to grow at a faster pace during the forecast period.

The application segment is divided into three categories: drug discovery & development, agriculture, and other applications. The largest segment is drug discovery & development, as CRISPR technology enhances early-stage research by facilitating the identification of connections between genes and diseases, as well as drug functions. This approach helps reduce timelines and increase the likelihood of success. Additionally, pharmaceutical & biotechnology companies are integrating CRISPR into their research and development processes to advance personalized medicine, gene therapy, and functional genomics, thereby enhancing the utilization of CRISPR technology.

Pharmaceutical & biotechnology companies dominated the CRISPR products market, by end user, in 2024.

Based on end users, the CRISPR products market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and other end users. In 2024, pharmaceutical & biotechnology companies dominated this market. This dominance is driven by increasing investments in cell and gene therapies, as well as the demand for precise genetic tools for target identification and validation. These companies rely heavily on CRISPR technologies, and their strong financial capacity allows them to adopt advanced and customized CRISPR products at scale, further contributing to their significant market share.

North America accounted for the largest share of the CRISPR market in 2024.

The market is divided by region into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America holds the largest share of the CRISPR market and is expected to maintain its lead. This dominance is attributed to the presence of prominent research institutions and significant investments in biotechnology. Additionally, the growing emphasis on cutting-edge medical research, personalized medicine, and precision medicine in the US gives North America a competitive advantage. The European CRISPR market is also experiencing steady growth, fueled by increased research and development efforts, particularly in countries such as Germany, the UK, and France.

In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the CRISPR market.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side (70%) and Demand Side (30%)
  • By Designation: Managers (45%), CXOs & Directors (30%), and Executives (25%)
  • By Region: North America (35%), Europe (30%), Asia Pacific (25%), Latin America (5%), and the Middle East & Africa (5%)
The prominent players operating in the CRISPR market are Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), GenScript (US), Takara Bio (Japan), Creative Biogene (US), Fujian SunyBiotech Co., Ltd. (China), EditCo (US), Caribou Biosciences, Inc. (US), Lonza Group (Switzerland), Danaher Corporation (US), Revvity, Inc. (US), Hera BioLabs (US), OriGene Technologies, Inc. (US), Cellecta, Inc. (US), Mammoth Biosciences, Inc. (US), Applied StemCell (US), New England Biolabs Inc. (US), ToolGen Inc. (South Korea), GeneCopoeia, Inc. (US), Twist Bioscience Corporation (US), Synthego Corporation (US), eGenesis (US), Inscripta, Inc. (US), and Precision BioSciences, Inc. (US), among others.

Research Coverage:

The CRISPR market report is segmented based on offerings [products (CRISPR kits & enzymes, CRISPR libraries, and other products), services (gRNA synthesis & cell line development, screening & validation, and other services)], applications (drug discovery & development, agriculture, and other applications), and end users [product (pharmaceutical & biotechnology companies, academic & research institutes, and other end users), and service (pharmaceutical & biotechnology companies, academic & research institutes, and other end users)].

The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the CRISPR market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. The report also covers new launches, collaborations, acquisitions, and recent developments associated with the CRISPR market.

Key Benefits of Buying the Report:

The report will assist both market leaders and new entrants by providing accurate revenue estimates for CRISPR and its subsegments. It will also help stakeholders better understand the competitive landscape, enabling them to position their businesses effectively and develop suitable go-to-market strategies. Additionally, this report will allow stakeholders to gauge the market dynamics and offer insights into the key drivers, restraints, opportunities, and challenges within the market.

The report provides insights into the following pointers:

  • Analysis of key drivers (growing demand for CRISPR-based gene therapies, advancements in CRISPR technology, and growing government and private investments and funding for CRISPR technology), restraints (technical challenges associated with CRISPR technology), opportunities (development of new vaccines and treatments for genetic diseases and expanding industrial and agricultural applications of CRISPR), and challenges (regulatory hurdles for CRISPR advancements) influencing the growth of the market.
  • Product Development/Innovation: In-depth analysis of emerging technologies in CRISPR, R&D activities, and new product launches in the CRISPR market.
  • Market Development: The report provides detailed information about profitable markets and analyzes the market conditions across various regions.
  • Market Diversification: Comprehensive information about new products, unexplored regions, recent updates, and investments in the CRISPR market.
  • Competitive Assessment: Comprehensive evaluation of market shares, growth strategies, and product & service offerings of leading companies such as Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), and GenScript (US).

Table of Contents

1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered & Regional Scope
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.3.4 Currency Considered
1.4 Stakeholders
1.5 Summary of Changes
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Research
2.2 Market Size Estimation
2.2.1 Global Market Estimation
2.2.1.1 Insights From Primary Experts
2.2.2 Segmental Market Estimation (Top-Down Approach)
2.3 Market Growth Rate Projection
2.4 Data Triangulation
2.5 Research Assumptions
2.6 Research Limitations
2.7 Risk Analysis
3 Executive Summary
4 Premium Insights
4.1 Crispr Market Overview
4.2 North America: Crispr Market, by Application and Country (2024)
4.3 Crispr Market Share, by End User, 2025 Vs. 2030
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Demand for Crispr-Based Gene Therapies
5.2.1.2 Advancements in Crispr Technology
5.2.1.3 Growing Government and Private Investments and Funding for Crispr Technology
5.2.2 Restraints
5.2.2.1 Technical Challenges Associated With Crispr Technology
5.2.3 Opportunities
5.2.3.1 Development of New Vaccines and Treatments for Genetic Diseases
5.2.3.2 Expanding Industrial and Agricultural Applications of Crispr
5.2.4 Challenges
5.2.4.1 Regulatory Hurdles for Crispr Advancements
5.2.5 Technology Analysis
5.2.5.1 Key Technologies
5.2.5.1.1 Crispr-Cas Systems
5.2.5.1.2 Grna Design & Optimization
5.2.5.1.3 High-Throughput Crispr Screening
5.2.5.2 Complementary Technologies
5.2.5.2.1 Synthetic Biology
5.2.5.2.2 Single-Cell Genomics
5.2.5.2.3 Next-Generation Sequencing
5.2.5.3 Adjacent Technologies
5.2.5.3.1 Stem Cell Engineering
5.2.5.3.2 Synthetic Dna & Gene Synthesis
5.2.5.3.3 Microfluidics
5.3 Trends/Disruptions Impacting Customers’ Businesses
5.4 Supply Chain Analysis
5.5 Value Chain Analysis
5.6 Ecosystem Analysis
5.7 Porter's Five Forces Analysis
5.7.1 Threat of New Entrants
5.7.2 Threat of Substitutes
5.7.3 Bargaining Power of Buyers
5.7.4 Bargaining Power of Suppliers
5.7.5 Intensity of Competitive Rivalry
5.8 Regulatory Analysis
5.8.1 Regulatory Bodies, Government Agencies, and Other Organizations
5.8.2 Regulatory Framework
5.8.2.1 North America
5.8.2.1.1 Us
5.8.2.1.2 Canada
5.8.2.2 Europe
5.8.2.2.1 Germany
5.8.2.2.2 Uk
5.8.2.2.3 France
5.8.2.3 Asia Pacific
5.8.2.3.1 Japan
5.8.2.3.2 China
5.8.2.4 Latin America
5.8.2.4.1 Brazil
5.8.2.5 Middle East & Africa
5.8.2.5.1 Gcc Countries
5.8.2.5.2 South Africa
5.9 Pricing Analysis
5.9.1 Average Selling Price of Kits and Reagents, by Key Player (2024)
5.9.2 Average Selling Price Trend of Crispr Kits & Reagents, by Key Player, 2022-2024
5.9.3 Indicative Price Trend for Crispr Services
5.9.4 Average Selling Price Trend of Crispr Kits and Reagents, by Region, 2024
5.10 Patent Analysis
5.11 Key Conferences & Events, 2025-2026
5.12 Key Stakeholders & Buying Criteria
5.12.1 Key Stakeholders in Buying Process
5.12.2 Crispr Market: Buying Criteria
5.13 Investment & Funding Scenario
5.14 Impact of Ai on Crispr Market
5.15 Trade Analysis
5.15.1 Import Data for Kits & Reagents, 2019-2023
5.15.2 Export Data for Kits & Reagents, 2019-2023
5.15.3 Trump Impact Overview: Crispr Market
5.15.3.1 Introduction
5.15.3.2 Key Tariff Rates
5.15.3.3 Price Impact Analysis
5.15.3.4 Key Impact on Various Regions
5.15.3.4.1 Us
5.15.3.4.2 Europe
5.15.3.4.3 Asia Pacific
5.15.3.4.4 Rest of the World
5.15.3.5 End-Use Industry Impact
5.15.3.5.1 Pharmaceutical & Biotech Companies
5.15.3.5.2 Contract Research Organizations (Cros)
5.15.3.5.3 Academic & Research Institutes
6 Crispr Market, by Offering
6.1 Introduction
6.2 Products
6.2.1 Advancements in Genome Editing to Drive Growth
6.3 Services
6.3.1 Growing Demand for Precise Genome Editing Tools in Research and Clinical Applications to Boost Market
7 Crispr Products Market, by Type
7.1 Introduction
7.2 Crispr Kits & Enzymes
7.2.1 Crispr Kits & Enzymes Segment to Dominate Crispr Products Market During Forecast Period
7.3 Crispr Libraries
7.3.1 Increasing Applications of Crispr Libraries in Gene Editing to Drive Growth
7.4 Other Products
8 Crispr Products Market, by End User
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.2.1 Increasing Product Approvals and Robust Clinical Pipeline to Propel Market
8.3 Academic & Research Institutes
8.3.1 Increasing Funding for Genomic Projects to Propel Market
8.4 Other End Users
9 Crispr Market, by Service
9.1 Introduction
9.1.1 Grna Synthesis & Cell Line Development
9.1.1.1 Emerging Opportunities in Crispr Grna Synthesis & Cell Line Development to Drive Growth
9.1.2 Screening & Validation
9.1.2.1 Rapid Advancements in Crispr Technology to Drive Growth
9.2 Other Services
10 Crispr Services Market, by End User
10.1 Introduction
10.2 Pharmaceutical & Biotechnology Companies
10.2.1 Advancements in Genome Editing to Drive Growth
10.3 Academic & Research Institutes
10.3.1 Increasing Investments in Genomic Projects to Propel Market
10.4 Other End Users
11 Crispr Market, by Application
11.1 Introduction
11.2 Drug Discovery & Development
11.2.1 Advancements in Genome Editing to Drive Growth
11.3 Agriculture
11.3.1 Growing Demand for Enhanced Crop Traits to Drive Growth
11.4 Other Applications
12 Crispr Market, by Region
12.1 Introduction
12.2 North America
12.2.1 Macroeconomic Outlook of North America
12.2.2 Us
12.2.2.1 Increasing Demand for Crispr Products and Services Across Various Industries to Drive Growth
12.2.3 Canada
12.2.3.1 Increasing Demand for Gene-Editing Technologies to Boost Growth
12.3 Europe
12.3.1 Macroeconomic Outlook of Europe
12.3.2 Germany
12.3.2.1 Rapidly Increasing Biotechnology Sector to Support Growth
12.3.3 Uk
12.3.3.1 Significant Government Investments in Genomics Research to Propel Growth
12.3.4 France
12.3.4.1 Increasing Demand for Targeted Therapies and Personalized Medicine to Propel Growth
12.3.5 Italy
12.3.5.1 Increasing Demand for Innovative Therapeutic Solutions to Drive Growth
12.3.6 Spain
12.3.6.1 Increasing Demand for Precision Medicine to Drive Growth
12.3.7 Rest of Europe
12.4 Asia Pacific
12.4.1 Macroeconomic Outlook for Asia Pacific
12.4.2 China
12.4.2.1 Increasing Investments in R&D to Drive Growth
12.4.3 Japan
12.4.3.1 Potential of Crispr-Based Therapies in Personalized Medicine to Present Opportunities for Market Growth
12.4.4 India
12.4.4.1 Increasing Prevalence of Genetic Disorders to Support Growth
12.4.5 Rest of Asia Pacific
12.5 Latin America
12.5.1 Macroeconomic Outlook for Latin America
12.5.2 Brazil
12.5.2.1 Growing Adoption of Genome Technologies to Propel Growth
12.5.3 Rest of Latin America
12.6 Middle East & Africa
12.6.1 Macroeconomic Outlook for Middle East & Africa
13 Competitive Landscape
13.1 Introduction
13.2 Key Player Strategy/Right to Win
13.2.1 Overview of Strategies Adopted by Key Players in Crispr Market
13.3 Revenue Analysis, 2020-2024
13.4 Market Share Analysis, 2024
13.5 Company Evaluation Matrix: Key Players, 2024
13.5.1 Stars
13.5.2 Emerging Leaders
13.5.3 Pervasive Players
13.5.4 Participants
13.5.5 Company Footprint: Key Players, 2024
13.5.5.1 Company Footprint
13.5.5.2 Region Footprint
13.5.5.3 Product Footprint
13.5.5.4 Service Footprint
13.5.5.5 Application Footprint
13.6 Company Evaluation Matrix: Startups/Smes, 2024
13.6.1 Progressive Companies
13.6.2 Responsive Companies
13.6.3 Dynamic Companies
13.6.4 Starting Blocks
13.6.5 Competitive Benchmarking: Startups/Smes
13.6.5.1 Detailed List of Key Startups/Smes
13.6.5.2 Competitive Benchmarking of Key Startups/Smes
13.7 Competitive Scenario
13.7.1 Product Launches & Approvals
13.7.2 Deals
13.7.3 Expansions
13.8 Company Valuation & Financial Metrics
13.9 Brand/Product Comparison
14 Company Profiles
14.1 Key Players
14.1.1 Thermo Fisher Scientific Inc.
14.1.1.1 Business Overview
14.1.1.2 Products/Services Offered
14.1.1.3 Recent Developments
14.1.1.3.1 Product/Service Launches
14.1.1.3.2 Deals
14.1.1.3.3 Expansions
14.1.1.4 The Analyst's View
14.1.1.4.1 Key Strengths
14.1.1.4.2 Strategic Choices
14.1.1.4.3 Weaknesses & Competitive Threats
14.1.2 Merck Kgaa
14.1.2.1 Business Overview
14.1.2.2 Products/Services Offered
14.1.2.3 Recent Developments
14.1.2.3.1 Deals
14.1.2.4 The Analyst's View
14.1.2.4.1 Key Strengths
14.1.2.4.2 Strategic Choices
14.1.2.4.3 Weaknesses & Competitive Threats
14.1.3 Agilent Technologies, Inc.
14.1.3.1 Business Overview
14.1.3.2 Products/Services Offered
14.1.3.3 Recent Developments
14.1.3.3.1 Deals
14.1.3.3.2 Expansions
14.1.3.4 The Analyst's View
14.1.3.4.1 Key Strengths
14.1.3.4.2 Strategic Choices
14.1.3.4.3 Weaknesses & Competitive Threats
14.1.4 Genscript
14.1.4.1 Business Overview
14.1.4.2 Products/Services Offered
14.1.4.3 Recent Developments
14.1.4.3.1 Product/Service Approvals/Launches
14.1.4.3.2 Deals
14.1.4.3.3 Expansions
14.1.5 Revvity
14.1.5.1 Business Overview
14.1.5.2 Products/Services Offered
14.1.5.3 Recent Developments
14.1.5.3.1 Deals
14.1.6 Lonza
14.1.6.1 Business Overview
14.1.6.2 Products/Services Offered
14.1.6.3 Recent Developments
14.1.6.3.1 Deals
14.1.7 Danaher Corporation
14.1.7.1 Business Overview
14.1.7.2 Products/Services Offered
14.1.7.3 Recent Developments
14.1.7.3.1 Deals
14.1.8 Takara Bio Inc.
14.1.8.1 Business Overview
14.1.8.2 Products/Services Offered
14.1.8.3 Recent Developments
14.1.8.3.1 Deals
14.1.9 Creative Biogene
14.1.9.1 Business Overview
14.1.9.2 Products/Services Offered
14.1.9.3 Recent Developments
14.1.9.3.1 Product/Service Approvals/Launches
14.1.10 Fujian Sunybiotech Co., Ltd.
14.1.10.1 Business Overview
14.1.10.2 Products/Services Offered
14.1.11 Editco
14.1.11.1 Business Overview
14.1.11.2 Products/Services Offered
14.1.11.3 Recent Financials
14.1.11.3.1 Deals
14.1.12 Caribou Biosciences, Inc.
14.1.12.1 Business Overview
14.1.12.2 Products/Services Offered
14.1.12.3 Recent Developments
14.1.12.3.1 Deals
14.1.13 Hera Biolabs
14.1.13.1 Business Overview
14.1.13.2 Products/Services Offered
14.1.14 Origene Technologies, Inc.
14.1.14.1 Business Overview
14.1.14.2 Products/Services Offered
14.1.15 Cellecta, Inc.
14.1.15.1 Business Overview
14.1.15.2 Products/Services Offered
14.2 Other Players
14.2.1 Mammoth Biosciences, Inc.
14.2.2 Applied Stemcell
14.2.3 New England Biolabs
14.2.4 Toolgen, Inc.
14.2.5 Genecopoeia, Inc.
14.2.6 Twist Bioscience
14.2.7 Synthego
14.2.8 Egenesis
14.2.9 Inscripta, Inc.
14.2.10 Precision Biosciences
15 Appendix
15.1 Discussion Guide
15.2 Knowledgestore: The Subscription Portal
15.3 Customization Options
15.4 Related Reports
15.5 Author Details
List of Tables
Table 1 Impact Analysis of Supply-Side and Demand-Side Factors
Table 2 Crispr Market: Risk Analysis
Table 3 Crispr Market: Impact Analysis
Table 4 Crispr Market: Role of Companies in Ecosystem
Table 5 Crispr Market: Porter’S Five Forces Analysis
Table 6 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 7 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 8 Asia Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 9 Latin America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 10 Middle East & Africa: Regulatory Bodies, Government Agencies, and Other Organizations
Table 11 Average Selling Price Trend of Crispr Kits & Reagents, by Key Player, 2022-2024
Table 12 Average Selling Price Trend of Crispr Kits and Reagents, by Region, 2024 (Usd)
Table 13 Crispr Market: Innovations and Patent Registrations
Table 14 Crispr Market: Key Conferences & Events, 2025-2026
Table 15 Crispr Market: Influence of Stakeholders on Buying Process (%)
Table 16 Import Data for Kits & Reagents, by Region, 2019-2023 (Usd)
Table 17 Export Data for Kits & Reagents, by Region, 2019-2023 (Usd)
Table 18 Us-Adjusted Reciprocal Tariff Rates
Table 19 Key Tariffs on Pharmaceutical Products
Table 20 Critical Components Likely Exposed to Tariff Changes
Table 21 Crispr Market, by Offering, 2023-2030 (Usd Million)
Table 22 Crispr Products Market, by Region, 2023-2030 (Usd Million)
Table 23 North America: Crispr Products Market, by Country, 2023-2030 (Usd Million)
Table 24 Europe: Crispr Products Market, by Country, 2023-2030 (Usd Million)
Table 25 Asia Pacific: Crispr Products Market, by Country, 2023-2030 (Usd Million)
Table 26 Latin America: Crispr Products Market, by Country, 2023-2030 (Usd Million)
Table 27 Crispr Services Market, by Region, 2023-2030 (Usd Million)
Table 28 North America: Crispr Services Market, by Country, 2023-2030 (Usd Million)
Table 29 Europe: Crispr Services Market, by Country, 2023-2030 (Usd Million)
Table 30 Asia Pacific: Crispr Services Market, by Country, 2023-2030 (Usd Million)
Table 31 Latin America: Crispr Services Market, by Country, 2023-2030 (Usd Million)
Table 32 Crispr Products Market, by Type, 2023-2030 (Usd Million)
Table 33 Crispr Kits & Enzymes Market, by Region, 2023-2030 (Usd Million)
Table 34 North America: Crispr Kits & Enzymes Market, by Country, 2023-2030 (Usd Million)
Table 35 Europe: Crispr Kits & Enzymes Market, by Country, 2023-2030 (Usd Million)
Table 36 Asia Pacific: Crispr Kits & Enzymes Market, by Country, 2023-2030 (Usd Million)
Table 37 Latin America: Crispr Kits & Enzymes Market, by Country, 2023-2030 (Usd Million)
Table 38 Crispr Libraries Market, by Region, 2023-2030 (Usd Million)
Table 39 North America: Crispr Libraries Market, by Country, 2023-2030 (Usd Million)
Table 40 Europe: Crispr Libraries Market, by Country, 2023-2030 (Usd Million)
Table 41 Asia Pacific: Crispr Libraries Market, by Country, 2023-2030 (Usd Million)
Table 42 Latin America: Crispr Libraries Market, by Country, 2023-2030 (Usd Million)
Table 43 Other Crispr Products Market, by Region, 2023-2030 (Usd Million)
Table 44 North America: Other Crispr Products Market, by Country, 2023-2030 (Usd Million)
Table 45 Europe: Other Crispr Products Market, by Country, 2023-2030 (Usd Million)
Table 46 Asia Pacific: Other Crispr Products Market, by Country, 2023-2030 (Usd Million)
Table 47 Latin America: Other Crispr Products Market, by Country, 2023-2030 (Usd Million)
Table 48 Crispr Products Market, by End User, 2023-2030 (Usd Million)
Table 49 Crispr Products Market for Pharmaceutical & Biotechnology Companies, by Region, 2023-2030 (Usd Million)
Table 50 North America: Crispr Products Market for Pharmaceutical & Biotechnology Companies, by Country, 2023-2030 (Usd Million)
Table 51 Europe: Crispr Products Market for Pharmaceutical & Biotechnology Companies, by Country, 2023-2030 (Usd Million)
Table 52 Asia Pacific: Crispr Products Market for Pharmaceutical & Biotechnology Companies, by Country, 2023-2030 (Usd Million)
Table 53 Latin America: Crispr Products Market for Pharmaceutical & Biotechnology Companies, by Country, 2023-2030 (Usd Million)
Table 54 Crispr Products Market for Academic & Research Institutes, by Region, 2023-2030 (Usd Million)
Table 55 North America: Crispr Products Market for Academic & Research Institutes, by Country, 2023-2030 (Usd Million)
Table 56 Europe: Crispr Products Market for Academic & Research Institutes, by Country, 2023-2030 (Usd Million)
Table 57 Asia Pacific: Crispr Products Market for Academic & Research Institutes, by Country, 2023-2030 (Usd Million)
Table 58 Latin America: Crispr Products Market for Academic & Research Institutes, by Country, 2023-2030 (Usd Million)
Table 59 Crispr Products Market for Other End Users, by Region, 2023-2030 (Usd Million)
Table 60 North America: Crispr Products Market for Other End Users, by Country, 2023-2030 (Usd Million)
Table 61 Europe: Crispr Products Market for Other End Users, by Country, 2023-2030 (Usd Million)
Table 62 Asia Pacific: Crispr Products Market for Other End Users, by Country, 2023-2030 (Usd Million)
Table 63 Latin America: Crispr Products Market for Other End Users, by Country, 2023-2030 (Usd Million)
Table 64 Crispr Market, by Service, 2023-2030 (Usd Million)
Table 65 Crispr Services Market for Grna Synthesis & Cell Line Development, by Region, 2023-2030 (Usd Million)
Table 66 North America: Crispr Services Market for Grna Synthesis & Cell Line Development, by Country, 2023-2030 (Usd Million)
Table 67 Europe: Crispr Services Market for Grna Synthesis & Cell Line Development, by Country, 2023-2030 (Usd Million)
Table 68 Asia Pacific: Crispr Services Market for Grna Synthesis & Cell Line Development, by Country, 2023-2030 (Usd Million)
Table 69 Latin America: Crispr Services Market for Grna Synthesis & Cell Line Development, by Country, 2023-2030 (Usd Million)
Table 70 Crispr Services Market for Screening & Validation, by Region, 2023-2030 (Usd Million)
Table 71 North America: Crispr Services Market for Screening & Validation, by Country, 2023-2030 (Usd Million)
Table 72 Europe: Crispr Services Market for Screening & Validation, by Country, 2023-2030 (Usd Million)
Table 73 Asia Pacific: Crispr Services Market for Screening & Validation, by Country, 2023-2030 (Usd Million)
Table 74 Latin America: Crispr Services Market for Screening & Validation, by Country, 2023-2030 (Usd Million)
Table 75 Other Crispr Services Market, by Region, 2023-2030 (Usd Million)
Table 76 North America: Other Crispr Services Market, by Country, 2023-2030 (Usd Million)
Table 77 Europe: Other Crispr Services Market, by Country, 2023-2030 (Usd Million)
Table 78 Asia Pacific: Other Crispr Services Market, by Country, 2023-2030 (Usd Million)
Table 79 Latin America: Other Crispr Services Market, by Country, 2023-2030 (Usd Million)
Table 80 Crispr Services Market, by End User, 2023-2030 (Usd Million)
Table 81 Crispr Services Market for Pharmaceutical & Biotechnology Companies, by Region, 2023-2030 (Usd Million)
Table 82 North America: Crispr Services Market for Pharmaceutical & Biotechnology Companies, by Country, 2023-2030 (Usd Million)
Table 83 Europe: Crispr Services Market for Pharmaceutical & Biotechnology Companies, by Country, 2023-2030 (Usd Million)
Table 84 Asia Pacific: Crispr Services Market for Pharmaceutical & Biotechnology Companies, by Country, 2023-2030 (Usd Million)
Table 85 Latin America: Crispr Services Market for Pharmaceutical & Biotechnology Companies, by Country, 2023-2030 (Usd Million)
Table 86 Crispr Services Market for Academic & Research Institutes, by Region, 2023-2030 (Usd Million)
Table 87 North America: Crispr Services Market for Academic & Research Institutes, by Country, 2023-2030 (Usd Million)
Table 88 Europe: Crispr Services Market for Academic & Research Institutes, by Country, 2023-2030 (Usd Million)
Table 89 Asia Pacific: Crispr Services Market for Academic & Research Institutes, by Country, 2023-2030 (Usd Million)
Table 90 Latin America: Crispr Services Market for Academic & Research Institutes, by Country, 2023-2030 (Usd Million)
Table 91 Crispr Services Market for Other End Users, by Region, 2023-2030 (Usd Million)
Table 92 North America: Crispr Services Market for Other End Users, by Country, 2023-2030 (Usd Million)
Table 93 Europe: Crispr Services Market for Other End Users, by Country, 2023-2030 (Usd Million)
Table 94 Asia Pacific: Crispr Services Market for Other End Users, by Country, 2023-2030 (Usd Million)
Table 95 Latin America: Crispr Services Market for Other End Users, by Country, 2023-2030 (Usd Million)
Table 96 Crispr Market, by Application, 2023-2030 (Usd Million)
Table 97 Crispr Market for Drug Discovery & Development Applications, by Region, 2023-2030 (Usd Million)
Table 98 North America: Crispr Market for Drug Discovery & Development Applications, by Country, 2023-2030 (Usd Million)
Table 99 Europe: Crispr Market for Drug Discovery & Development Applications, by Country, 2023-2030 (Usd Million)
Table 100 Asia Pacific: Crispr Market for Drug Discovery & Development Applications, by Country, 2023-2030 (Usd Million)
Table 101 Latin America: Crispr Market for Drug Discovery & Development Applications, by Country, 2023-2030 (Usd Million)
Table 102 Crispr Market for Agricultural Applications, by Region, 2023-2030 (Usd Million)
Table 103 North America: Crispr Market for Agricultural Applications, by Country, 2023-2030 (Usd Million)
Table 104 Europe: Crispr Market for Agricultural Applications, by Country, 2023-2030 (Usd Million)
Table 105 Asia Pacific: Crispr Market for Agricultural Applications, by Country, 2023-2030 (Usd Million)
Table 106 Latin America: Crispr Market for Agricultural Applications, by Country, 2023-2030 (Usd Million)
Table 107 Crispr Market for Other Applications, by Region, 2023-2030 (Usd Million)
Table 108 North America: Crispr Market for Other Applications, by Country, 2023-2030 (Usd Million)
Table 109 Europe: Crispr Market for Other Applications, by Country, 2023-2030 (Usd Million)
Table 110 Asia Pacific: Crispr Market for Other Applications, by Country, 2023-2030 (Usd Million)
Table 111 Latin America: Crispr Market for Other Applications, by Country, 2023-2030 (Usd Million)
Table 112 Crispr Market, by Region, 2023-2030 (Usd Million)
Table 113 North America: Key Macroindicators
Table 114 North America: Crispr Market, by Offering, 2023-2030 (Usd Million)
Table 115 North America: Crispr Market, by Product, 2023-2030 (Usd Million)
Table 116 North America: Crispr Products Market, by End User, 2023-2030 (Usd Million)
Table 117 North America: Crispr Market, by Service, 2023-2030 (Usd Million)
Table 118 North America: Crispr Market, by Application, 2023-2030 (Usd Million)
Table 119 North America: Crispr Services Market, by End User, 2023-2030 (Usd Million)
Table 120 Us: Crispr Market, by Offering, 2023-2030 (Usd Million)
Table 121 Us: Crispr Market, by Product, 2023-2030 (Usd Million)
Table 122 Us: Crispr Products Market, by End User, 2023-2030 (Usd Million)
Table 123 Us: Crispr Market, by Service, 2023-2030 (Usd Million)
Table 124 Us: Crispr Market, by Application, 2023-2030 (Usd Million)
Table 125 Us: Crispr Services Market, by End User, 2023-2030 (Usd Million)
Table 126 Canada: Crispr Market, by Offering, 2023-2030 (Usd Million)
Table 127 Canada: Crispr Market, by Product, 2023-2030 (Usd Million)
Table 128 Canada: Crispr Products Market, by End User, 2023-2030 (Usd Million)
Table 129 Canada: Crispr Market, by Service, 2023-2030 (Usd Million)
Table 130 Canada: Crispr Market, by Application, 2023-2030 (Usd Million)
Table 131 Canada: Crispr Services Market, by End User, 2023-2030 (Usd Million)
Table 132 Europe: Key Macroindicators
Table 133 Europe: Crispr Market, by Country, 2023-2030 (Usd Million)
Table 134 Europe: Crispr Market, by Offering, 2023-2030 (Usd Million)
Table 135 Europe: Crispr Market, by Product, 2023-2030 (Usd Million)
Table 136 Europe: Crispr Products Market, by End User, 2023-2030 (Usd Million)
Table 137 Europe: Crispr Market, by Service, 2023-2030 (Usd Million)
Table 138 Europe: Crispr Market, by Application, 2023-2030 (Usd Million)
Table 139 Europe: Crispr Services Market, by End User, 2023-2030 (Usd Million)
Table 140 Germany: Crispr Market, by Offering, 2023-2030 (Usd Million)
Table 141 Germany: Crispr Market, by Product, 2023-2030 (Usd Million)
Table 142 Germany: Crispr Products Market, by End User, 2023-2030 (Usd Million)
Table 143 Germany: Crispr Market, by Service, 2023-2030 (Usd Million)
Table 144 Germany: Crispr Market, by Application, 2023-2030 (Usd Million)
Table 145 Germany: Crispr Services Market, by End User, 2023-2030 (Usd Million)
Table 146 Uk: Crispr Market, by Offering, 2023-2030 (Usd Million)
Table 147 Uk: Crispr Market, by Product, 2023-2030 (Usd Million)
Table 148 Uk: Crispr Products Market, by End User, 2023-2030 (Usd Million)
Table 149 Uk: Crispr Market, by Service, 2023-2030 (Usd Million)
Table 150 Uk: Crispr Market, by Application, 2023-2030 (Usd Million)
Table 151 Uk: Crispr Services Market, by End User, 2023-2030 (Usd Million)
Table 152 France: Crispr Market, by Offering, 2023-2030 (Usd Million)
Table 153 France: Crispr Market, by Product, 2023-2030 (Usd Million)
Table 154 France: Crispr Products Market, by End User, 2023-2030 (Usd Million)
Table 155 France: Crispr Market, by Service, 2023-2030 (Usd Million)
Table 156 France: Crispr Market, by Application, 2023-2030 (Usd Million)
Table 157 France: Crispr Services Market, by End User, 2023-2030 (Usd Million)
Table 158 Italy: Crispr Market, by Offering, 2023-2030 (Usd Million)
Table 159 Italy: Crispr Market, by Product, 2023-2030 (Usd Million)
Table 160 Italy: Crispr Products Market, by End User, 2023-2030 (Usd Million)
Table 161 Italy: Crispr Market, by Service, 2023-2030 (Usd Million)
Table 162 Italy: Crispr Market, by Application, 2023-2030 (Usd Million)
Table 163 Italy: Crispr Services Market, by End User, 2023-2030 (Usd Million)
Table 164 Spain: Crispr Market, by Offering, 2023-2030 (Usd Million)
Table 165 Spain: Crispr Market, by Product, 2023-2030 (Usd Million)
Table 166 Spain: Crispr Products Market, by End User, 2023-2030 (Usd Million)
Table 167 Spain: Crispr Market, by Service, 2023-2030 (Usd Million)
Table 168 Spain: Crispr Market, by Application, 2023-2030 (Usd Million)
Table 169 Spain: Crispr Services Market, by End User, 2023-2030 (Usd Million)
Table 170 Rest of Europe: Crispr Market, by Offering, 2023-2030 (Usd Million)
Table 171 Rest of Europe: Crispr Market, by Product, 2023-2030 (Usd Million)
Table 172 Rest of Europe: Crispr Market, by Service, 2023-2030 (Usd Million)
Table 173 Rest of Europe: Crispr Products Market, by End User, 2023-2030 (Usd Million)
Table 174 Rest of Europe: Crispr Market, by Application, 2023-2030 (Usd Million)
Table 175 Rest of Europe: Crispr Services Market, by End User, 2023-2030 (Usd Million)
Table 176 Asia Pacific: Key Macro Indicators
Table 177 Asia Pacific: Crispr Market, by Country, 2023-2030 (Usd Million)
Table 178 Asia Pacific: Crispr Market, by Offering, 2023-2030 (Usd Million)
Table 179 Asia Pacific: Crispr Market, by Product, 2023-2030 (Usd Million)
Table 180 Asia Pacific: Crispr Products Market, by End User, 2023-2030 (Usd Million)
Table 181 Asia Pacific: Crispr Market, by Service, 2023-2030 (Usd Million)
Table 182 Asia Pacific: Crispr Market, by Application, 2023-2030 (Usd Million)
Table 183 Asia Pacific: Crispr Services Market, by End User, 2023-2030 (Usd Million)
Table 184 China: Crispr Market, by Offering, 2023-2030 (Usd Million)
Table 185 China: Crispr Market, by Product, 2023-2030 (Usd Million)
Table 186 China: Crispr Products Market, by End User, 2023-2030 (Usd Million)
Table 187 China: Crispr Market, by Service, 2023-2030 (Usd Million)
Table 188 China: Crispr Market, by Application, 2023-2030 (Usd Million)
Table 189 China: Crispr Services Market, by End User, 2023-2030 (Usd Million)
Table 190 Japan: Crispr Market, by Offering, 2023-2030 (Usd Million)
Table 191 Japan: Crispr Market, by Product, 2023-2030 (Usd Million)
Table 192 Japan: Crispr Products Market, by End User, 2023-2030 (Usd Million)
Table 193 Japan: Crispr Market, by Service, 2023-2030 (Usd Million)
Table 194 Japan: Crispr Market, by Application, 2023-2030 (Usd Million)
Table 195 Japan: Crispr Services Market, by End User, 2023-2030 (Usd Million)
Table 196 India: Crispr Market, by Offering, 2023-2030 (Usd Million)
Table 197 India: Crispr Market, by Product, 2023-2030 (Usd Million)
Table 198 India: Crispr Products Market, by End User, 2023-2030 (Usd Million)
Table 199 India: Crispr Market, by Service, 2023-2030 (Usd Million)
Table 200 India: Crispr Market, by Application, 2023-2030 (Usd Million)
Table 201 India: Crispr Services Market, by End User, 2023-2030 (Usd Million)
Table 202 Rest of Asia Pacific: Crispr Market, by Offering, 2023-2030 (Usd Million)
Table 203 Rest of Asia Pacific: Crispr Market, by Product, 2023-2030 (Usd Million)
Table 204 Rest of Asia Pacific: Crispr Products Market, by End User, 2023-2030 (Usd Million)
Table 205 Rest of Asia Pacific: Crispr Market, by Service, 2023-2030 (Usd Million)
Table 206 Rest of Asia Pacific: Crispr Market, by Application, 2023-2030 (Usd Million)
Table 207 Rest of Asia Pacific: Crispr Services Market, by End User, 2023-2030 (Usd Million)
Table 208 Latin America: Key Macroindicators
Table 209 Latin America: Crispr Market, by Country, 2023-2030 (Usd Million)
Table 210 Latin America: Crispr Market, by Offering, 2023-2030 (Usd Million)
Table 211 Latin America: Crispr Market, by Product, 2023-2030 (Usd Million)
Table 212 Latin America: Crispr Products Market, by End User, 2023-2030 (Usd Million)
Table 213 Latin America: Crispr Market, by Service, 2023-2030 (Usd Million)
Table 214 Latin America: Crispr Market, by Application, 2023-2030 (Usd Million)
Table 215 Latin America: Crispr Services Market, by End User, 2023-2030 (Usd Million)
Table 216 Brazil: Crispr Market, by Offering, 2023-2030 (Usd Million)
Table 217 Brazil: Crispr Market, by Product, 2023-2030 (Usd Million)
Table 218 Brazil: Crispr Products Market, by End User, 2023-2030 (Usd Million)
Table 219 Brazil: Crispr Market, by Service, 2023-2030 (Usd Million)
Table 220 Brazil: Crispr Market, by Application, 2023-2030 (Usd Million)
Table 221 Brazil: Crispr Services Market, by End User, 2023-2030 (Usd Million)
Table 222 Rest of Latin America: Crispr Market, by Offering, 2023-2030 (Usd Million)
Table 223 Rest of Latin America: Crispr Market, by Product, 2023-2030 (Usd Million)
Table 224 Rest of Latin America: Crispr Products Market, by End User, 2023-2030 (Usd Million)
Table 225 Rest of Latin America: Crispr Market, by Service, 2023-2030 (Usd Million)
Table 226 Rest of Latin America: Crispr Market, by Application, 2023-2030 (Usd Million)
Table 227 Rest of Latin America: Crispr Services Market, by End User, 2023-2030 (Usd Million)
Table 228 Middle East & Africa: Key Macroindicators
Table 229 Middle East & Africa: Crispr Market, by Offering, 2023-2030 (Usd Million)
Table 230 Middle East & Africa: Crispr Market, by Product, 2023-2030 (Usd Million)
Table 231 Middle East & Africa: Crispr Products Market, by End User, 2023-2030 (Usd Million)
Table 232 Middle East & Africa: Crispr Market, by Service, 2023-2030 (Usd Million)
Table 233 Middle East & Africa: Crispr Market, by Application, 2023-2030 (Usd Million)
Table 234 Middle East & Africa: Crispr Services Market, by End User, 2023-2030 (Usd Million)
Table 235 Strategies Adopted by Key Players in Crispr Market, 2021-2025
Table 236 Crispr Market: Degree of Competition
Table 237 Crispr Market: Region Footprint
Table 238 Crispr Market: Product Footprint
Table 239 Crispr Market: Service Footprint
Table 240 Crispr Market: Application Footprint
Table 241 Crispr Market: Detailed List of Key Startups/Smes
Table 242 Crispr Market: Competitive Benchmarking of Key Start Ups/Smes
Table 243 Crispr Market: Product Launches, January 2021-March 2025
Table 244 Crispr Market: Deals, January 2021-March 2025
Table 245 Crispr Market: Expansions, January 2021-March 2025
Table 246 Thermo Fisher Scientific Inc.: Company Overview
Table 247 Thermo Fisher Scientific Inc.: Products/Services Offered
Table 248 Thermo Fisher Scientific Inc.: Product/Service Launches, January 2021-January 2025
Table 249 Thermo Fisher Scientific Inc.: Deals, January 2021-January 2025
Table 250 Thermo Fisher Scientific Inc.: Expansions, January 2021-January 2025
Table 251 Merck Kgaa: Company Overview
Table 252 Merck Kgaa: Products/Services Offered
Table 253 Merck Kgaa: Deals, January 2021-January 2025
Table 254 Agilent Technologies, Inc.: Company Overview
Table 255 Agilent Technologies, Inc.: Products/Services Offered
Table 256 Agilent Technologies, Inc.: Deals, January 2021-March 2025
Table 257 Agilent Technologies, Inc.: Expansions, January 2021-March 2025
Table 258 Genscript: Company Overview
Table 259 Genscript: Products/Services Offered
Table 260 Genscript: Product/Service Approvals/Launches, January 2021-March 2025
Table 261 Genscript: Deals, January 2021-March 2025
Table 262 Genscript: Expansions, January 2021-March 2025
Table 263 Revvity: Company Overview
Table 264 Revvity: Products/Services Offered
Table 265 Revvity: Deals, January 2021-March 2025
Table 266 Lonza: Company Overview
Table 267 Lonza: Products/Services Offered
Table 268 Lonza: Deals, January 2021-March 2025
Table 269 Danaher Corporation: Company Overview
Table 270 Danaher Corporation: Products/Services Offered
Table 271 Danaher Corporation: Deals, January 2021-March 2025
Table 272 Takara Bio Inc.: Company Overview
Table 273 Takara Bio Inc.: Products/Services Offered
Table 274 Takara Bio Inc.: Deals, January 2021-March 2025
Table 275 Creative Biogene: Company Overview
Table 276 Creative Biogene: Products/Services Offered
Table 277 Creative Biogene: Product/Service Approvals/Launches, January 2021-March 2025
Table 278 Fujian Sunybiotech Co., Ltd.: Company Overview
Table 279 Fujian Sunybiotech Co., Ltd.: Products/Services Offered
Table 280 Editco: Company Overview
Table 281 Editco: Products/Services Offered
Table 282 Editco: Deals, January 2021-March 2025
Table 283 Caribou Biosciences, Inc.: Company Overview
Table 284 Caribou Biosciences, Inc.: Products/Services Offered
Table 285 Caribou Biosciences, Inc.: Deals, January 2021-March 2025
Table 286 Hera Biolabs: Company Overview
Table 287 Hera Biolabs: Products/Services Offered
Table 288 Origene Technologies, Inc.: Company Overview
Table 289 Origene Technologies, Inc.: Products/Services Offered
Table 290 Cellecta, Inc.: Company Overview
Table 291 Cellecta, Inc.: Products/Services Offered
Table 292 Mammoth Biosciences, Inc.: Company Overview
Table 293 Applied Stemcell: Company Overview
Table 294 New England Biolabs: Company Overview
Table 295 Toolgen, Inc.: Company Overview
Table 296 Genecopoeia, Inc.: Company Overview
Table 297 Twist Bioscience: Company Overview
Table 298 Synthego: Company Overview
Table 299 Egenesis: Company Overview
Table 300 Inscripta, Inc.: Company Overview
Table 301 Precision Biosciences: Company Overview
List of Figures
Figure 1 Crispr Market Segmentation & Regional Scope
Figure 2 Crispr Market: Research Design
Figure 3 Crispr Market: Breakdown of Primary Interviews
Figure 4 Crispr Market Size Estimation (Supply-Side Analysis), 2024
Figure 5 Crispr Market Estimation: Approach 1 (Company Revenue Analysis-Based Estimation), 2024
Figure 6 Illustrative Example of Thermo Fisher Scientific Inc.: Revenue Share Analysis (2024)
Figure 7 Market Size Validation From Primary Sources
Figure 8 Segmental Market Size Estimation Methodology: Top-Down Approach
Figure 9 Crispr Market: CAGR Projections
Figure 10 Data Triangulation Methodology
Figure 11 Crispr Market, by Offering, 2025 Vs. 2030 (Usd Million)
Figure 12 Crispr Market, by Application, 2025 Vs. 2030 (Usd Million)
Figure 13 Crispr Market: Geographical Snapshot
Figure 14 Rising Focus on Crispr Therapeutics Development to Drive Growth
Figure 15 Drug Discovery & Development Segment to Account for Largest Market Share in 2024
Figure 16 Pharmaceutical & Biotechnology Companies to Account for Largest Market Share During Forecast Period
Figure 17 Crispr Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Top 10 Leading Crispr Startups Based on Investments Raised in 2024
Figure 19 Crispr Market: Trends/Disruptions Impacting Customers’ Businesses
Figure 20 Crispr Market: Supply Chain Analysis
Figure 21 Crispr Market: Value Chain Analysis
Figure 22 Crispr Market: Ecosystem Analysis
Figure 23 Crispr Market: Porter’S Five Forces Analysis
Figure 24 Average Selling Price of Kits and Reagents, by Key Player (2024)
Figure 25 Average Selling Price of Kits & Reagents, by Region, 2024 (Usd)
Figure 26 Patent Applications for Crispr (January 2014-December 2024)
Figure 27 Crispr Market: Influence of Stakeholders on Buying Process
Figure 28 Key Buying Criteria of End Users for Crispr Products
Figure 29 Key Selection Criteria of End Users for Crispr Services
Figure 30 Crispr Market: Investment & Funding Scenario
Figure 31 Impact of Ai/Gen Ai on Crispr Market
Figure 32 North America: Crispr Market Snapshot
Figure 33 Asia Pacific: Crispr Market Snapshot
Figure 34 Revenue Analysis of Key Players in Crispr Market, 2020-2024
Figure 35 Market Share Analysis of Key Players in Crispr Market, 2024
Figure 36 Crispr Market: Company Evaluation Matrix (Key Players), 2024
Figure 37 Crispr Market: Company Footprint
Figure 38 Crispr Market: Company Evaluation Matrix (Startups/Smes), 2024
Figure 39 Year-to-Date (Ytd) Price Total Return and 5-Year Stock Beta of Key Vendors, 2024
Figure 40 Ev/Ebitda of Key Players, 2024
Figure 41 Crispr Market: Brand/Product Comparison
Figure 42 Thermo Fisher Scientific Inc.: Company Snapshot (2024)
Figure 43 Merck Kgaa: Company Snapshot (2024)
Figure 44 Agilent Technologies, Inc.: Company Snapshot (2024)
Figure 45 Genscript: Company Snapshot (2023)
Figure 46 Revvity: Company Snapshot (2024)
Figure 47 Lonza: Company Snapshot (2024)
Figure 48 Danaher Corporation: Company Snapshot (2024)
Figure 49 Takara Bio Inc.: Company Snapshot (2023)
Figure 50 Caribou Biosciences, Inc.: Company Snapshot (2024)

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Genscript
  • Revvity
  • Lonza
  • Danaher Corporation
  • Takara Bio Inc.
  • Creative Biogene
  • Fujian Sunybiotech Co. Ltd.
  • Editco
  • Caribou Biosciences, Inc.
  • Hera Biolabs
  • Origene Technologies, Inc.
  • Cellecta, Inc.
  • Mammoth Biosciences, Inc.
  • Applied Stemcell
  • New England Biolabs
  • Toolgen, Inc.
  • Genecopoeia, Inc.
  • Twist Bioscience
  • Synthego
  • Egenesis
  • Inscripta, Inc.
  • Precision Biosciences

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages267
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.21 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.47 Billion
Compound Annual Growth Rate11.2%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

CRISPR And Cas Genes Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Cell Line Engineering), By Application (Biomedical, Agricultural), By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

CRISPR And Cas Genes Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Cell Line Engineering), By Application (Biomedical, Agricultural), By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
CRISPR and Cas Gene Market Opportunities and Strategies to 2033 - Product Image

CRISPR and Cas Gene Market Opportunities and Strategies to 2033

  • Report
  • 338 Pages
  • Global
From
CRISPR Technology Market by Offering, Delivery Method, Application, End-User - Global Forecast to 2030 - Product Image

CRISPR Technology Market by Offering, Delivery Method, Application, End-User - Global Forecast to 2030

  • Report
  • 180 Pages
  • Global
From
CRISPR & Cas Genes Market by Application, End User, Cas Type, Delivery Method, Technology - Global Forecast to 2030 - Product Image

CRISPR & Cas Genes Market by Application, End User, Cas Type, Delivery Method, Technology - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
CRISPR-based Gene Editing Market Size, Share and Trends Analysis Report by Product & Service (CRISPR Kits & Reagents), Application (Biomedical, Agricultural), End-use, and Region 2024-2030 - Product Image

CRISPR-based Gene Editing Market Size, Share and Trends Analysis Report by Product & Service (CRISPR Kits & Reagents), Application (Biomedical, Agricultural), End-use, and Region 2024-2030

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.